How Pharma and Its Consultants Abuse the Patent System
Dec 2023: Patent Abuse is Front-Page News
Oct. 2023: How Egregious Orange Book Manipulation Extended an Insulin Monopoly
The COVID-19 Vaccine Patent Waiver Fight Is Far From Over
Patently unfair: Can waivers help solve COVID vaccine inequality?
The Path to Racial Justice Runs Through This Agency
We Need to Take On Drug Companies’ Abuse of the Patent System
AbbVie Proves Masterful at Playing Drug Patent Game
AbbVie, already famous for its Humira strategy, forms another ‘patent wall’ around Imbruvica: report
An Entrepreneur’s Quest To Fix Drug Patents And Save Lives